Hypertonic saline use in neurocritical care for treating cerebral edema: A review of optimal formulation, dosing, safety, administration and storage

Author:

Holden Devin N1,Mucksavage Jeffrey J2,Cokley John A3,Kim Keri S4,Tucker Natalie L5,Esordi Molly S6,Cook Aaron M7

Affiliation:

1. Albany Medical Center Hospital , Albany, NY , USA

2. University of Illinois Chicago College of Pharmacy , Chicago, IL , USA

3. Texas Children’s Hospital, Baylor College of Medicine , Houston, TX , USA

4. University of Illinois Health , Chicago, IL , USA

5. Ochsner Medical Center , New Orleans, LA , USA

6. Texas Children’s Hospital , Houston, TX , USA

7. University of Kentucky Chandler Medical Center , Lexington, KY , USA

Abstract

AbstractPurposeCurrent Neurocritical Care Society guidelines on the management of cerebral edema recommend hypertonic saline (HTS) over mannitol in some scenarios, but practical questions remain regarding the appropriate administration method, concentration/dose, monitoring to ensure safe use, and storage. The aim of this article is to address these practical concerns based on the evidence currently available.SummaryMany different hypertonic solutions have been studied to define the optimal hyperosmolar substance to relieve acute cerebral edema in patients with conditions such as acute ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, and traumatic brain injury. Mannitol and HTS are the main hyperosmolar therapies in use in contemporary neurocritical care practice. Contemporary use of HTS has followed a circuitous path in regards to the practical aspects of dosing and formulation, with evidence mainly consisting of retrospective or observational data. The effectiveness of bolus doses of HTS to lower acutely elevated intracranial pressure is well accepted. Adverse events with use of HTS are often mild and non–clinically significant if appropriate monitoring of serum sodium and chloride concentrations is performed. Available evidence shows that peripheral administration of HTS is likely safe in certain circumstances. Timely utilization of HTS is complicated by regulatory requirements for safe storage, but with appropriate safeguards HTS can be stored in patient care areas.ConclusionHTS formulations, methods of administration, infusion rate, and storage vary by institution, and no practice standards exist. Central intravenous administration may be preferred for HTS, but peripheral intravenous administration is safe provided measures are undertaken to detect and prevent phlebitis and extravasation. The safe use of HTS is possible with proper protocols, education, and institutional safeguards in place.

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Reference100 articles.

1. Osmotherapy for intracranial hypertension: mannitol versus hypertonic saline;Fink;Continuum (Minneapolis, Minn),2012

2. The Monro-Kellie hypothesis: applications in CSF volume depletion;Mokri;Neurology,2001

3. The medical management of cerebral edema: past, present, and future therapies;Halstead;Neurotherapeutics,2019

4. Guidelines for the management of severe traumatic brain injury, fourth edition;Carney;Neurosurgery,2017

5. Guidelines for the acute treatment of cerebral edema in neurocritical care patients;Cook;Neurocrit Care,2020

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3